Explore best practices for developing and validating rare event flow cytometry assays in regulated environments.

This webinar examines the unique challenges of detecting rare cell populations using flow cytometry and introduces Design Control as a structured approach to assay development and validation. Learn how applying Design Control principles can improve assay robustness, reproducibility, and regulatory readiness for research, clinical laboratories, and drug development.

In this webinar, you'll learn:

• The challenges of developing and validating rare event flow cytometry assays
• How Design Control supports robust assay development and implementation
• Best practices for measuring rare cell populations in research, clinical, and regulated settings
• Applications of rare event analysis for stem cells, minimal residual disease (MRD), CAR T-cell therapies, and other advanced therapeutic programs

As advanced therapies and precision medicine continue to evolve, reliable rare event analysis is essential for generating high-quality data and supporting regulatory confidence. Discover how Design Control and validated flow cytometry strategies can improve assay performance throughout clinical development.